Syra Health Earns ISO 27001:2022 Certification, Highlighting Company's Commitment to Data Protection
Syra Health (OTCQB: SYRA) has achieved ISO 27001:2022 certification, demonstrating its commitment to information security management. This certification is particularly significant for the company's AI-backed mental health app, Syrenity, which handles sensitive user data.
The certification validates Syra Health's comprehensive framework for managing information security risks and comes alongside the company's proprietary Syra Guardrails framework for ethical AI use in healthcare. The certification was granted following an independent audit of the company's security systems and procedures.
Syra Health (OTCQB: SYRA) ha ottenuto la certificazione ISO 27001:2022, dimostrando il suo impegno nella gestione della sicurezza delle informazioni. Questa certificazione 猫 particolarmente rilevante per l'app di salute mentale supportata dall'intelligenza artificiale dell'azienda, Syrenity, che gestisce dati sensibili degli utenti.
La certificazione attesta il solido quadro di Syra Health per la gestione dei rischi legati alla sicurezza delle informazioni e si affianca al framework proprietario dell'azienda, Syra Guardrails, dedicato all'uso etico dell'IA in ambito sanitario. La certificazione 猫 stata concessa a seguito di un audit indipendente sui sistemi e sulle procedure di sicurezza dell'azienda.
Syra Health (OTCQB: SYRA) ha obtenido la certificaci贸n ISO 27001:2022, demostrando su compromiso con la gesti贸n de la seguridad de la informaci贸n. Esta certificaci贸n es especialmente importante para la aplicaci贸n de salud mental respaldada por IA de la empresa, Syrenity, que maneja datos sensibles de los usuarios.
La certificaci贸n valida el marco integral de Syra Health para gestionar los riesgos de seguridad de la informaci贸n y se suma al marco propietario de la empresa, Syra Guardrails, para el uso 茅tico de la IA en la atenci贸n sanitaria. La certificaci贸n fue otorgada tras una auditor铆a independiente de los sistemas y procedimientos de seguridad de la empresa.
Syra Health (OTCQB: SYRA)臧赌 ISO 27001:2022 鞚胳鞚� 須嶋摑頃橃棳 鞝曤炒 氤挫晥 甏毽棎 雽頃� 鞚橃毳� 鞛呾頄堨姷雼堧嫟. 鞚� 鞚胳鞚 氙缄皭頃� 靷毄鞛� 雿办澊韯半ゼ 觳橂Μ頃橂姅 須岇偓鞚� AI 旮半皹 鞝曥嫚 瓯搓皶 鞎膘澑 Syrenity鞐� 韸鬼瀳 欷戩殧頃╇媹雼�.
鞚� 鞚胳鞚 Syra Health鞚� 鞝曤炒 氤挫晥 鞙勴棙 甏毽棎 雽頃� 韽磩鞝侅澑 頂勲爤鞛勳泴韥ゼ 瓴歃濏晿氅�, 鞚橂 攵勳暭鞐愳劀 鞙るΜ鞝侅澑 AI 靷毄鞚� 鞙勴暅 須岇偓 瓿犾湢鞚� Syra Guardrails 頂勲爤鞛勳泴韥檧 頃粯 鞝滉车霅╇媹雼�. 鞚� 鞚胳鞚 須岇偓鞚� 氤挫晥 鞁滌姢韰� 氚� 鞝堨皑鞐� 雽頃� 霃呺鞝侅澑 臧愳偓 頉勳棎 攵鞐悩鞐堨姷雼堧嫟.
Syra Health (OTCQB : SYRA) a obtenu la certification ISO 27001:2022, d茅montrant son engagement envers la gestion de la s茅curit茅 de l'information. Cette certification est particuli猫rement importante pour l'application de sant茅 mentale soutenue par l'IA de l'entreprise, Syrenity, qui traite des donn茅es sensibles des utilisateurs.
La certification valide le cadre complet de Syra Health pour la gestion des risques li茅s 脿 la s茅curit茅 de l'information et s'accompagne du cadre propri茅taire de l'entreprise, Syra Guardrails, pour une utilisation 茅thique de l'IA dans le domaine de la sant茅. La certification a 茅t茅 accord茅e suite 脿 un audit ind茅pendant des syst猫mes et proc茅dures de s茅curit茅 de l'entreprise.
Syra Health (OTCQB: SYRA) hat die ISO 27001:2022-Zertifizierung erhalten und damit sein Engagement f眉r das Informationssicherheitsmanagement unter Beweis gestellt. Diese Zertifizierung ist besonders wichtig f眉r die KI-gest眉tzte Mental-Health-App des Unternehmens, Syrenity, die sensible Nutzerdaten verarbeitet.
Die Zertifizierung best盲tigt den umfassenden Rahmen von Syra Health zur Verwaltung von Informationssicherheitsrisiken und erg盲nzt den firmeneigenen Syra Guardrails-Rahmen f眉r den ethischen Einsatz von KI im Gesundheitswesen. Die Zertifizierung wurde nach einer unabh盲ngigen Pr眉fung der Sicherheitsysteme und -verfahren des Unternehmens vergeben.
- Achieved ISO 27001:2022 certification, enhancing credibility in data security
- Established Syra Guardrails framework for ethical AI use in healthcare
- Independent validation of security systems through accredited auditor
- None.
This certification underscores Syra Health's commitment to data protection and security, particularly important for tools like , the company's science-based and AI-backed mental and behavioral health app that collects and processes sensitive user information.
"As more and more individuals come to rely on Syrenity, we are reinforcing our dedication to safeguarding personal and health information," said Priya Prasad, interim CEO of Syra Health. "This certification demonstrates to our customers and partners that we take data privacy seriously and operate with integrity and transparency across our digital products and operations."
In addition to its ISO 27001 certification, Syra Health offers Syra Guardrails, a proprietary framework designed to guide the safe and ethical use of AI in healthcare. Syra Guardrails further reinforces the company's leadership in responsible digital health innovation.
The ISO 27001 certification means that Syra Health has established a comprehensive and continually improving framework to identify, assess, and manage information security risks. This includes robust controls and governance structures that maintain accountability while enabling the confidentiality and integrity of information assets across its systems.
"Our mental and behavioral health platform is built on a foundation of security and privacy," said Prasad. "Achieving ISO 27001 certification is a thorough validation of our processes and a signal to our stakeholders that their information is in safe hands."
The certification was issued by an accredited, independent auditor following a rigorous assessment of Syra Health's systems, policies, and procedures.
About Syra Health
Syra Health is a healthcare technology company that powers better health in critical areas such as mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit .
Forward-Looking Statements
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For Investor or Media Inquiries:
Christine Drury
Director of Corporate Communications
Syra Health
463-345-5180
[email protected]
View original content to download multimedia:
SOURCE Syra Health